Research graph
References from Cystatin C-based eGFR discordance and mortality risk in adults with dysglycemia. Local targets link to admitted publications; unresolved targets remain external evidence.
IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.
10.1016/j.diabres.2021.109119 · 2022 · External reference
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
10.1016/s0140-6736(10)60484-9 · 2010 · External reference
Diabetes mellitus, fasting glucose, and risk of cause-specific death.
10.1056/nejmoa1008862 · 2011 · External reference
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
10.1136/bmj.m2297 · 2020 · External reference
Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014.
10.1001/jama.2016.10924 · 2016 · External reference
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.
10.1016/s0140-6736(12)61350-6 · 2012 · External reference
10. Cardiovascular disease and risk management: standards of care in diabetes-2026.
10.2337/dc26-s010 · 2026 · External reference
11. Chronic kidney disease and risk management: standards of care in diabetes-2026.
10.2337/dc26-s011 · 2026 · External reference
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
10.2337/dci22-0027 · 2022 · External reference
Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update.
10.7326/m22-2904 · 2023 · External reference
Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns.
10.1016/j.kint.2023.10.016 · 2024 · External reference
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
10.1016/s0140-6736(10)60674-5 · 2010 · External reference
A new equation to estimate glomerular filtration rate.
10.7326/0003-4819-150-9-200905050-00006 · 2009 · External reference
Estimating glomerular filtration rate from serum creatinine and cystatin C.
10.1056/nejmoa1114248 · 2012 · External reference
New creatinine- and cystatin C-based equations to estimate GFR without race.
10.1056/nejmoa2102953 · 2021 · External reference
Factors other than glomerular filtration rate affect serum cystatin C levels.
10.1038/ki.2008.638 · 2009 · External reference
Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD.
10.1053/j.ajkd.2016.07.021 · 2016 · External reference
Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR.
10.34067/kid.0003202022 · 2022 · External reference
Cystatin C versus creatinine in determining risk based on kidney function.
10.1056/nejmoa1214234 · 2013 · External reference
Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
10.1001/jama.2011.468 · 2011 · External reference
Cystatin C identifies chronic kidney disease patients at higher risk for complications.
10.1681/asn.2010050483 · 2011 · External reference
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study.
10.1161/circulationaha.106.644286 · 2007 · External reference
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
10.1161/circheartfailure.112.966960 · 2012 · External reference
Discordance in creatinine- and cystatin C-based eGFR and clinical outcomes: a meta-analysis.
10.1001/jama.2025.17578 · 2025 · External reference
Complex etiologies of the discordance between cystatin C- and creatinine-based estimated GFR and its adverse associations: findings from the CRIC study.
10.1053/j.ajkd.2025.03.018 · 2025 · External reference
Cystatin C-based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ckj/sfac070 · 2022 · External reference
Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ije/dys203 · 2014 · External reference
Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
10.1001/jama.2011.468 · ExternalCitation · doi-reference
Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014.
10.1001/jama.2016.10924 · ExternalCitation · doi-reference
Discordance in creatinine- and cystatin C-based eGFR and clinical outcomes: a meta-analysis.
10.1001/jama.2025.17578 · ExternalCitation · doi-reference
IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.
10.1016/j.diabres.2021.109119 · ExternalCitation · doi-reference
Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns.
10.1016/j.kint.2023.10.016 · ExternalCitation · doi-reference
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
10.1016/s0140-6736(10)60484-9 · ExternalCitation · doi-reference
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
10.1016/s0140-6736(10)60674-5 · ExternalCitation · doi-reference
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.
10.1016/s0140-6736(12)61350-6 · ExternalCitation · doi-reference
Factors other than glomerular filtration rate affect serum cystatin C levels.
10.1038/ki.2008.638 · ExternalCitation · doi-reference
Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD.
10.1053/j.ajkd.2016.07.021 · ExternalCitation · doi-reference
Complex etiologies of the discordance between cystatin C- and creatinine-based estimated GFR and its adverse associations: findings from the CRIC study.
10.1053/j.ajkd.2025.03.018 · ExternalCitation · doi-reference
Diabetes mellitus, fasting glucose, and risk of cause-specific death.
10.1056/nejmoa1008862 · ExternalCitation · doi-reference
Estimating glomerular filtration rate from serum creatinine and cystatin C.
10.1056/nejmoa1114248 · ExternalCitation · doi-reference
Cystatin C versus creatinine in determining risk based on kidney function.
10.1056/nejmoa1214234 · ExternalCitation · doi-reference
New creatinine- and cystatin C-based equations to estimate GFR without race.
10.1056/nejmoa2102953 · ExternalCitation · doi-reference
Cystatin C-based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ckj/sfac070 · ExternalCitation · doi-reference
Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS).
10.1093/ije/dys203 · ExternalCitation · doi-reference
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
10.1136/bmj.m2297 · ExternalCitation · doi-reference
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
10.1161/circheartfailure.112.966960 · ExternalCitation · doi-reference
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the heart and soul study.
10.1161/circulationaha.106.644286 · ExternalCitation · doi-reference
Cystatin C identifies chronic kidney disease patients at higher risk for complications.
10.1681/asn.2010050483 · ExternalCitation · doi-reference
10. Cardiovascular disease and risk management: standards of care in diabetes-2026.
10.2337/dc26-s010 · ExternalCitation · doi-reference
11. Chronic kidney disease and risk management: standards of care in diabetes-2026.
10.2337/dc26-s011 · ExternalCitation · doi-reference
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
10.2337/dci22-0027 · ExternalCitation · doi-reference
Advantages, limitations, and clinical considerations in using cystatin C to estimate GFR.
10.34067/kid.0003202022 · ExternalCitation · doi-reference
A new equation to estimate glomerular filtration rate.
10.7326/0003-4819-150-9-200905050-00006 · ExternalCitation · doi-reference
Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update.
10.7326/m22-2904 · ExternalCitation · doi-reference
